OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
Company Published White Paper titled, "Parachuting Behind Enemy Lines: OncoSec's Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)"
White Paper Unveils Ability to Directly Deliver Plasmid-Based IL-12 to Pancreatic, Liver a... Biopharmaceuticals, Oncology, Drug Delivery OncoSec Medical, Visceral Lesion Applicator, intratumoral, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Immunotherapy | Liver | Pancreas | Pharmaceuticals | Urology & Nephrology